PAVmed (PAVM) Non Operating Investment Income (2024 - 2025)
PAVmed's (PAVM) quarterly Non Operating Investment Income came in at $2.5 million in Q4 2025, up 1903.2% year-on-year from $125000.0 in Q4 2024, and up 157.14% quarter-over-quarter from -$4.4 million in Q3 2025.
PAVmed (PAVM) Non Operating Investment Income (2024 - 2025) Analysis & Trends
PAVmed's Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- On a quarterly basis, Non Operating Investment Income rose 1903.2% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $8.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.5 million, up 1494.55% from the prior year.
- Non Operating Investment Income grew to $2.5 million in Q4 2025 per PAVM's latest filing, from -$4.4 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $21.0 million in Q1 2025 and bottomed at -$10.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | - |
| 10 | PAVmed | 11.35 Mn | 9.81 Mn | -4,000.00 | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | -4.38 Mn |
| Sep 30, 2025 | -4.38 Mn |
| Jun 30, 2025 | -10.64 Mn |
| Jun 30, 2025 | -10.64 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Dec 31, 2024 | 125,000.00 |
| Dec 31, 2024 | 125,000.00 |